Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’

Nathan Vastesaeger (1) , Bruno Fautrel (2, 3) , Josef Smolen (4)

1 Department of Medical Affairs, MSD Denmark ApS
2 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
3 CHU Pitié-Salpêtrière [AP-HP]
4 Medizinische Universität Wien = Medical University of Vienna

Markusse and colleagues recently investigated whether rheumatoid arthritis patient subgroups formed according to the presence of poor prognostic factors respond differently to initial monotherapy or combination therapy [1]. Since both poor- and good-prognosis subgroups experienced a better response to initial combination therapy, the authors concluded that patient-tailored treatment based on prognosis as suggested by the European League Against Rheumatism (EULAR) recommendations [2] is currently not feasible. [...]

Domaines: Rhumatologie et système ostéo-articulaire

Nathan Vastesaeger, Bruno Fautrel, Josef Smolen. Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’. Arthritis Research and Therapy, 2015, 17, pp.166. ⟨10.1186/s13075-015-0680-8⟩. ⟨hal-01256050⟩